SMMT – summit therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

SMMT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/11

09:56 am

smmt

Rating for SMMT

Low Report

Rating for SMMT

Report

12/11

09:56 am

smmt

Rating for SMMT

Low Report

Rating for SMMT

Report

12/11

09:04 am

smmt

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.

Low Report

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.

Report

12/11

06:58 am

smmt

Summit Therapeutics initiated with an Overweight at Wells Fargo

Low Report

Summit Therapeutics initiated with an Overweight at Wells Fargo

Report

12/11

06:58 am

smmt

Summit Therapeutics initiated with an Overweight at Wells Fargo

Low Report

Summit Therapeutics initiated with an Overweight at Wells Fargo

Report

12/6

09:03 am

smmt

Rating for SMMT

Medium Report

Rating for SMMT

Report

12/6

09:03 am

smmt

Rating for SMMT

Medium Report

Rating for SMMT

Report

12/6

06:40 am

smmt

Summit Therapeutics initiated with a Buy at Jefferies

Medium Report

Summit Therapeutics initiated with a Buy at Jefferies

Report

12/6

06:40 am

smmt

Summit Therapeutics initiated with a Buy at Jefferies

Medium Report

Summit Therapeutics initiated with a Buy at Jefferies

Report

11/18

08:07 am

smmt

Summit Therapeutics Inc. (NASDAQ: SMMT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $44.00 price target on the stock.

Low Report

Summit Therapeutics Inc. (NASDAQ: SMMT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $44.00 price target on the stock.

Report

11/4

08:19 am

smmt

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $32.00 price target on the stock.

Medium Report

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $32.00 price target on the stock.

Report

11/4

08:19 am

smmt

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $32.00 price target on the stock.

Medium Report

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $32.00 price target on the stock.

Report

11/4

05:01 am

smmt

Rating for SMMT

Medium Report

Rating for SMMT

Report

11/4

05:01 am

smmt

Rating for SMMT

Medium Report

Rating for SMMT

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.